Special items: Ovarian Cancer and Us blog best viewed in Firefox

Monday, August 09, 2010

Ovatax


New Data Demonstrates Effectiveness of Clarient’s Ovatax™ Test for Ovarian Cancer.

See study, titled “Expression of TLE3 Predicts Response to Taxane Therapy in Ovarian Carcinoma,” included 293 carcinoma samples mostly collected at UAB

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.